Breaking News

BPSI, Scentryphar Join Clinical Forces in Brazil

Aims to support drug development in the Brazilian market

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BioPharma Services Inc. (BPSI) has entered into a partnership and joint venture agreement with Scentryphar, a CRO located in Sao Paulo, Brazil. The partnership aims to support local and global sponsors’ generic and innovative drug development in the Brazilian market by offering joint expertise in clinical conduct, bioanalysis, data management, statistics as well as scientific and medical writing. BPSI is a physician-owned CRO that specializes in Phase I/IIa trials, including FIM trials, BE st...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters